o-Nitrotoluene

o-Nitrotoluene is produced by the nitration of toluene, a process developed in the mid-19th century that yields a mixture of ortho, meta, and para isomers. [1] The ortho isomer (o-nitrotoluene) is isolated by distillation and used as an intermediate in the synthesis of o-toluidine (a dye intermediate), azo dyes, rubber chemicals, and pesticide precursors. It is also used in the manufacture of o-amino-p-cresol (a photographic developer) and as an intermediate in the synthesis of several pharmaceutical compounds. NTP bioassays conducted in the late 1980s found clear evidence of carcinogenicity for o-nitrotoluene: hemangiosarcomas (vascular tumors), hepatocellular carcinomas (liver tumors), and kidney tubular cell tumors occurred in male and female rats and mice at doses that did not cause severe acute toxicity. [2] The EPA classified it as a Group B2 probable human carcinogen. The mechanism of carcinogenicity is thought to involve reduction of the nitro group by intestinal microflora to reactive nitroso and hydroxylamine intermediates, followed by their systemic distribution and reaction with DNA in target tissues. [3] o-Nitrotoluene is released to the environment primarily from chemical manufacturing facilities and is listed as a Hazardous Air Pollutant and TRI chemical.

Chemical manufacturing workers producing o-nitrotoluene or using it as a synthetic intermediate are the primary occupationally exposed population. Inhalation of vapors during processing and dermal absorption during handling are the main routes. Environmental releases from chemical plants can contaminate local air and water. General population exposures are very low and limited to trace environmental background levels.

The multi-organ carcinogenicity in rodent bioassays (hemangiosarcomas, liver carcinomas, kidney tumors) indicates a systemic carcinogenic effect rather than a localized one, suggesting the reactive metabolites are distributed throughout the body. The nitro group reduction mechanism — shared across the nitrotoluene family — is also relevant for mixed isomer occupational exposures. [2] Acute toxicity includes methemoglobin formation (the reduced metabolites can oxidize hemoglobin), CNS effects, and liver and kidney toxicity at high doses.

Chemical workers in facilities manufacturing o-nitrotoluene and its downstream derivatives (o-toluidine, azo dyes) face occupational risk. The general public has very low exposures from environmental background sources.

1. Industrial handling requires closed systems, local exhaust ventilation, and continuous air monitoring. 2. Workers must wear chemical-resistant gloves, eye protection, and respirators appropriate for organic vapors. 3. Biologically monitor workers with urinary metabolite testing where feasible. 4. Regular blood methemoglobin monitoring for workers with regular exposure. 5. Explore substitution with less toxic synthetic routes or intermediates.